Key result
Mitral valve repair was associated with a lower perioperative mortality but a higher recurrence of mitral regurgitation compared with replacement for severe ischemic mitral regurgitation.
Why the study?
Does mitral valve repair reduce perioperative mortality and improve long-term survival compared to mitral valve replacement in patients with severe ischemic mitral regurgitation?
Meta-Analysis (n=1,993)
Does mitral valve repair reduce perioperative mortality and improve long-term survival compared to mitral valve replacement in patients with severe ischemic mitral regurgitation?
In patients with severe ischemic mitral regurgitation, mitral valve repair is associated with lower perioperative mortality but higher MR recurrence compared to replacement, with no significant difference in long-term survival.
Answers are grounded in this paper and cite their sources.
Supports repair to lower perioperative mortality in severe ischemic MR; leaves optimal long-term strategy open given higher recurrence.
BACKGROUND: The best surgical option for severe ischemic mitral regurgitation (IMR) is still controversial. The aim of this study was to perform a meta-analysis to compare the clinical outcomes of mitral valve repair (MVP) with replacement (MVR). METHODS: A literature search was conducted in PubMed, Embase, and Medline using the terms "ischemic mitral regurgitation" and "repair or annuloplasty or reconstruction" and "replacement" in the title/abstract field. The primary outcomes of interest were perioperative mortality and long-term survival. Secondary outcomes were mitral regurgitation (MR) recurrence and reoperation. RESULTS: Of 276 studies, 13 studies met the inclusion and exclusion criteria. A total of 1993 patients were included in these studies, consisting of 1259 (63%) repair cases, and 734 (37%) replacement cases. Perioperative mortality was lower with MVP compared with MVR [OR 0.61; (95% CI, 0.43-0.87; P < .05)]. There was no difference with respect to long-term survival [HR 0.75; (95% CI, 0.52-1.09; P = .14)] and reoperation [OR 0.77; (95% CI, 0.38-1.57; P = .47)]. MVP is associated with a higher recurrence of MR [OR = 4.09; (95% CI, 1.82-9.19; P < .001)]. CONCLUSION: MVP is associated with a lower perioperative mortality but a higher recurrence of MR compared with MVR for severe IMR. No differences were found with respect to long-term survival and reoperation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2018) conducted a meta-analysis in Severe ischemic mitral regurgitation (n=1,993). Mitral valve repair vs. Mitral valve replacement was evaluated on Perioperative mortality (OR 0.61, 95% CI 0.43-0.87, p=<.05). Mitral valve repair was associated with a lower perioperative mortality but a higher recurrence of mitral regurgitation compared with replacement for severe ischemic mitral regurgitation.
Synapse has enriched 10 related papers. Consider them for comparative context: